Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

2377-2388 of 2541 results
Page 199 of 212
Key Publications December 11, 2015

Coronary heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women.

Circulation. 2015;132:997-1002

Wilmot KA, O'Flaherty M, Capewell S, Ford ES, Vaccarino V
Age Cardiovascular Disease Sex Differences
Key Publications December 10, 2015

Nonalcoholic fatty liver disease and statins.

Metabolism. 2015;64:1215-23

Tziomalos K, Athyros VG, Paschos P, Karagiannis A
Cardiovascular Disease Ectopic Fat Lipids/Lipoproteins
Key Publications December 10, 2015

Risk of major adverse cardiovascular events in patients with metabolic syndrome after revascularization: A meta-analysis of eighteen cohorts with 18457 patients.

Metabolism. 2015;64:1224-34

Tie HT, Shi R, Li ZH, Zhang M, Zhang C, Wu QC
Cardiovascular Disease Epidemiology Metabolic Syndrome
Key Publications December 9, 2015

Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) registry.

Circulation. 2015;132:923-31

Cavender MA, Steg PG, Smith SC Jr, Eagle K, Ohman EM, Goto S, Kuder J, Im K, Wilson PW, Bhatt DL, REACH Registry Investigators
Cardiovascular Disease Diabetes Epidemiology
Key Publications December 9, 2015

Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 American College of Cardiology/American Heart Association cholesterol guidelines.

Circulation. 2015;132:916-22

Yeboah J, Polonsky TS, Young R, McClelland RL, Delaney JC, Dawood F, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC Jr, Psaty BM, Greenland P, Herrington DM
Cardiovascular Disease Ethnicity Prevention
Key Publications December 8, 2015

Nontraditional markers of cardiovascular disease risk can improve the 2013 American College of Cardiology/American Heart Association prevention guidelines: insights from the Multi-Ethnic Study of Atherosclerosis investigation.

Circulation. 2015;132:904-6

Superko HR
Cardiovascular Disease Ethnicity Prevention
Key Publications December 4, 2015

Usefulness of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as predictors of cardiovascular disease in Chinese.

Am J Cardiol. 2015;116:1063-70

Gu X, Yang X, Li Y, Cao J, Li J, Liu X, Chen J, Shen C, Yu L, Huang J, Gu D
Cardiovascular Disease Ethnicity Lipids/Lipoproteins
Key Publications December 4, 2015

Impact of combined C-reactive protein and high-density lipoprotein cholesterol levels on long-term outcomes in patients with coronary artery disease after a first percutaneous coronary intervention.

Am J Cardiol. 2015;116:999-1002

Ogita M, Miyauchi K, Tsuboi S, Shitara J, Endo H, Wada H, Doi S, Naito R, Konishi H, Dohi T, Kasai T, Tamura H, Okazaki S, Suwa S, Daida H
Cardiovascular Disease Inflammation Lipids/Lipoproteins
Key Publications December 4, 2015

Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL.

Curr Opin Lipidol. 2015;26:388-93

Hutchins PM, Heinecke JW
Cardiovascular Disease Inflammation Lipids/Lipoproteins
Key Publications December 3, 2015

Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.

Eur Heart J. 2015;36:2288-96

Ferrannini E, DeFronzo RA
Cardiovascular Disease Diabetes Insulin Resistance
Key Publications December 3, 2015

Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis.

J Am Coll Cardiol. 2015;66:1236-46

Capoulade R, Chan KL, Yeang C, Mathieu P, Bossé Y, Dumesnil JG, Tam JW, Teo KK, Mahmut A, Yang X, Witztum JL, Arsenault BJ, Després JP, Pibarot P, Tsimikas S
Cardiovascular Disease Inflammation Lipids/Lipoproteins
Key Publications December 3, 2015

How does elevated lipoprotein(a) cause aortic valve stenosis?

J Am Coll Cardiol. 2015;66:1247-9

Nordestgaard BG, Langsted A
Cardiovascular Disease Inflammation Lipids/Lipoproteins
of 212